Literature DB >> 9645266

Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy.

L Matthiesen1, C Ekerfelt, G Berg, J Ernerudh.   

Abstract

PROBLEM: Systemic immune responses during normal pregnancy are suggested to deviate toward secretion of T helper (Th)2-like cytokines. METHOD OF STUDY: Blood samples from 11 healthy primigravidae in their first, second, and third trimesters, and 8 weeks postpartum were examined. Peripheral blood mononuclear cells were separated and the numbers of interferon (IFN)-gamma- and interleukin (IL)-4-secreting cells were identified by using the enzyme-linked immunospot test.
RESULTS: In all three trimesters of pregnancy, and also postpartum, the numbers of IFN-gamma- and IL-4-secreting cells were significantly higher compared with nonpregnant controls (Mann-Whitney; P < 0.001). The numbers of IFN-gamma- and IL-4-secreting cells gradually increased as the pregnancy progressed compared with postpartum (Kruskas-Wallis; P < 0.01 and P < 0.05, for IFN-gamma and IL-4, respectively). The ratios of IFN-gamma/IL-4 during pregnancy and postpartum were unchanged, and also when compared with nonpregnant controls.
CONCLUSION: The results indicate a systemic up-regulation of both Th1- and Th2-like immune responses during normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645266     DOI: 10.1111/j.1600-0897.1998.tb00370.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  14 in total

Review 1.  Preterm birth and single nucleotide polymorphisms in cytokine genes.

Authors:  Qin Zhu; Jian Sun; Ying Chen
Journal:  Transl Pediatr       Date:  2014-04

2.  A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy.

Authors:  H Tsuda; T Michimata; M Sakai; K Nagata; M Nakamura; S Saito
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Variations in cytokine mRNA expression during normal human pregnancy.

Authors:  N Kruse; M Greif; N F Moriabadi; L Marx; K V Toyka; P Rieckmann
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

4.  CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.

Authors:  Jenny Mjösberg; Göran Berg; Jan Ernerudh; Christina Ekerfelt
Journal:  Immunology       Date:  2007-01-11       Impact factor: 7.397

5.  Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia.

Authors:  S Saito; M Sakai; Y Sasaki; K Tanebe; H Tsuda; T Michimata
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Maternal body mass index is associated with an altered immunological profile at 28 weeks of gestation.

Authors:  April Rees; Oliver Richards; Anastasia Allen-Kormylo; Nicholas Jones; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

Review 7.  T helper cell immunity in pregnancy and influence on autoimmune disease progression.

Authors:  Jonathon J Graham; Maria Serena Longhi; Michael A Heneghan
Journal:  J Autoimmun       Date:  2021-05-18       Impact factor: 7.094

Review 8.  The Th1:th2 dichotomy of pregnancy and preterm labour.

Authors:  Lynne Sykes; David A MacIntyre; Xiao J Yap; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Mediators Inflamm       Date:  2012-06-07       Impact factor: 4.711

9.  Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2.

Authors:  Lynne Sykes; David A MacIntyre; Xiao J Yap; Sathana Ponnampalam; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Mediators Inflamm       Date:  2012-05-29       Impact factor: 4.711

Review 10.  The remission of rheumatoid arthritis during pregnancy.

Authors:  Monika Ostensen; Peter M Villiger
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.